UNITED STATES SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 19, 2000
VAXGEN, INC.
(Exact name of Registrant as Specified in its Charter)
COMMISSION FILE NUMBER 0-26483
DELAWARE
(State or other jurisdiction of incorporation or organization)
94-3236309
(I.R.S. Employer Identification Number)
1000 MARINA BLVD., SUITE 200
BRISBANE, CALIFORNIA 94005
(Address of Principal Administrative Offices) (Zip Code)
(650) 624-1000
(Registrants Telephone Number, Including Area Code)
NOT APPLICABLE
(Former Name or Former Address, if Changed Since Last Report)
<PAGE>
ITEM 5. OTHER EVENTS.
On December 19, 2000, the Registrant issued a press release, a copy of which is
attached hereto as Exhibit 99.1.
EXHIBIT NUMBER DESCRIPTION
Exhibit 99.1 Press Release of the Registrant, dated December 19, 2000.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
VaxGen, Inc.
(Registrant)
Dated: December 21, 2000 By: /s/ Carter A. Lee
---------------------------------
Carter A. Lee
Senior Vice President
Finance & Administration
(Principal Financial Officer)
